QFQesya Rodrigues Ferreira

Qesya Rodrigues Ferreira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qesya Rodrigues Ferreira has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Epidemiological and clinical profile of HTLV-1 patients: a closer look at a reference center in Bahia, Brazil

    by Jéssica Oliveira de Souza Nascimento, Daniele Leite Alves, Ana Flávia Novaes, Qesya Rodrigues Ferreira, Felipe de Oliveira Andrade, Roberta Muniz Luz Silva, Saadia Oliveira Ribeiro, Riviane Santana Souza, Luciane Amorim Santos, Thessika Hialla Almeida Araújo, et al.

    The human T-lymphotropic virus type 1 (HTLV-1) affects over 5 million people worldwide and is endemic in Brazil. Though HTLV-1 is a notifiable disease, the last epidemiological report regarding HTLV-1 infection covered the period from 2012 to 2019. To understand the specific challenges and to develop the best strategies for controlling HTLV-1 infection, it is important to know the characteristics of each region providing care to people living with this virus. This descriptive cross-sectional study evaluated patients treated at the HTLV reference center in Vitória da Conquista, Bahia, Brazil, between July 2021 and August 2022. The data were obtained through the analysis of medical records and routine clinical consultations. A total of 67 patients were evaluated, with 79.1% being female, 79.1% identifying as black, indigenous, and people of color, 37.31% being married, 80.6% identifying as heterosexual, and 59.7% reporting inconsistent condom use. Additionally, 37.3% of the patients were diagnosed with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic disease with a considerable effect on the quality of life. Furthermore, 53.7% of the patients had incomplete/complete elementary education, and 52.2% had an income of up to one minimum wage. The data highlight the necessity for more specific public policies (such as health education strategies, aimed at reducing the number of new infections) targeting the described at-risk population.


  • Neurological aspects of HTLV-1 infection: symptoms in apparently asymptomatic carriers

    by Qesya Rodrigues Ferreira, Ana Flávia Novaes, Carolina Souza Santana, Arthur Shigueru Umeda, Jéssica Oliveira de Souza Nascimento, João Pedro Melo de Freitas Santos, Larissa Alves Fernandes, Matheus Nascimento Moura, Rebeca Leão Amorim, Vinícius Nogueira Cavalcanti, et al.

    Human T-lymphotropic virus type 1 (HTLV-1) is classically associated with the HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), although the mechanisms of this neurological disorder remain unclear. In addition, some patients who develop “minor” neurological signs that do not meet diagnostic criteria for HAM/TSP are classified as asymptomatic carriers. This study aims to demonstrate the neurological symptoms of Brazilian patients living with HTLV-1 classified as not-HAM.TSP. This observational study evaluated patients treated in an HTLV reference center in Bahia, Brazil, between February 2022 and July 2023. The data were obtained through the analysis of medical records and neurological consultation. Those individuals classified as HAM/ TSP were excluded from this study. 74 patients were submitted to a careful neurological evaluation: 23 HAM/TSP, 22 were classified with intermediate syndrome (IS), and 29 were oligosymptomatic. Self-reported symptoms were significantly more common in the IS group, including urinary symptoms such as nocturia, urgency, incontinence, dysuria, weakness, paresthesia, lumbar pain, xerostomia, and xerophthalmia. Physical examination findings consistent with reduced vibratory and tactile sensitivity were more common in the IS group (p = 0.017 and p = 0.013). Alterations in the V and VIII cranial nerves were present in both groups. HTLV-1 can lead to the development of important neurological signs and symptoms in apparently asymptomatic individuals. This data highlights the need for more research into the neurological aspects of HTLV-1 infection and emphasizes the importance of early diagnosis, treatment, and support for individuals living with this virus.


  • Open Access

    Role of the Microbiome in Aedes spp. Vector Competence: What Do We Know?

    by Qesya Rodrigues Ferreira, Fabian Fellipe Bueno Lemos, Matheus Nascimento Moura, Jéssica Oliveira de Souza Nascimento, Ana Flávia Novaes, Isadora Souza Barcelos, Larissa Alves Fernandes, Liliany Souza de Brito Amaral, Fernanda Khouri Barreto, Fabrício Freire de Melo

    Aedes aegypti and Aedes albopictus are the vectors of important arboviruses: dengue fever, chikungunya, Zika, and yellow fever. Female mosquitoes acquire arboviruses by feeding on the infected host blood, thus being able to transmit it to their offspring. The intrinsic ability of a vector to infect itself and transmit a pathogen is known as vector competence. Several factors influence the susceptibility of these females to be infected by these arboviruses, such as the activation of the innate immune system through the Toll, immunodeficiency (Imd), JAK-STAT pathways, and the interference of specific antiviral response pathways of RNAi. It is also believed that the presence of non-pathogenic microorganisms in the microbiota of these arthropods could influence this immune response, as it provides a baseline activation of the innate immune system, which may generate resistance against arboviruses. In addition, this microbiome has direct action against arboviruses, mainly due to the ability of Wolbachia spp. to block viral genome replication, added to the competition for resources within the mosquito organism. Despite major advances in the area, studies are still needed to evaluate the microbiota profiles of Aedes spp. and their vector competence, as well as further exploration of the individual roles of microbiome components in activating the innate immune system.


  • Open Access

    Achados neuropatológicos da Covid-19: uma revisão sistemática

    by Qesya Rodrigues Ferreira, Bruna Teixeira da Costa, Marcelle Machado Mendes, Vinicius Nogueira Cavalcanti, Alberto Christian Luz Santos, David Manoel Pereira Araújo, Patrícia da Silva Oliveira

    Introdução. A doença causada pelo Sars-Cov-2, Covid-19, foi identificada pela primeira vez na China e apresentou rápida expansão mundial, sendo reconhecida como pandemia em março de 2020. Apesar de causar uma infecção de vias aéreas, descobertas clínicas recentes e estudos com animais sugerem que o vírus também promove vias neuronais notáveis e comprometimentos do sistema circulatório, levando a lesões no sistema nervoso central. Objetivo. Coletar e analisar os dados publicados entre 2019 e 2020 a respeito de lesões encontradas no sistema nervoso a partir de estudos de necrópsia e de imagem realizados em seres humanos. Método. Uma busca sistemática foi feita nas bases de dados PubMed e Science Direct utilizando os descritores “COVID-19” OU “SARS-CoV-2” OU “Coronavirus” AND “Central Nervous System” OU “Brain” AND “Autopsy” OR “RMI”. Foram incluídos estudos originais primários, publicados entre 2019 e 2020. Foram excluídos estudos realizados em animais, casos não comprovados de contaminação por COVID-19 e estudos in vitro. Resultados. Os principais achados desta revisão sistemática apontam para causas imunológicas, inflamatórias e infecciosas. Hemorragia intracranial e intracerebral e Acidente Vascular Cerebral (AVC) isquêmico foram os principais eventos relatados, sendo que o AVC relacionado a Covid-19 tende a ser mais grave do que outras causas. Conclusão. Embora os dados científicos ainda sejam escassos para explicar as vias de dano do SARS-CoV-2 no sistema nervoso central, as evidências disponíveis sugerem uma correlação entre COVID-19 e complicações neurológicas em alguns pacientes.